-+ 0.00%
-+ 0.00%
-+ 0.00%

ADARX PHARMACEUTICALS, INC.: FY2025 COLLABORATION REV ASSOCIATED WITH ABBVIE AGREEMENT $3.4 MLN, FY2025 NET LOSS $73.1 MLN - SEC FILING

Reuters·09/04/2026 21:25:20

Please log in to view news